* NRx Pharmaceuticals press release [https://seekingalpha.com/pr/20203549-nrx-pharmaceuticals-inc-nasdaq-nrxp-reports-second-quarter-2025-financial-results-and] (NASDAQ:NRXP [https://seekingalpha.com/symbol/NRXP]): Q2 net loss of $17.6 million versus a net loss of $7.9 million for the comparable quarter in 2024.
*
As of June 30, 2025, NRx Pharmaceuticals had approximately $2.9 million in cash and cash equivalents.
*
The company believes that its current cash position will support operations into 2026 and provide sufficient capital to reach expected regulatory inflection points.
MORE ON NRX PHARMACEUTICALS
* Seeking Alpha’s Quant Rating on NRx Pharmaceuticals [https://seekingalpha.com/symbol/NRXP/ratings/quant-ratings]
* Historical earnings data for NRx Pharmaceuticals [https://seekingalpha.com/symbol/NRXP/earnings]
* Financial information for NRx Pharmaceuticals [https://seekingalpha.com/symbol/NRXP/income-statement]
NRx Pharmaceuticals reports Q2 results
Published 2 months ago
Aug 19, 2025 at 5:50 AM
Neutral
Auto